Outcomes of two different polytetrafluoroethylene graft sizes in patients undergoing maintenance hemodialysis
- PMID: 20535250
- PMCID: PMC2875704
- DOI: 10.4103/0971-4065.59336
Outcomes of two different polytetrafluoroethylene graft sizes in patients undergoing maintenance hemodialysis
Abstract
Arteriovenous access creation is mandatory for maintenance hemodialysis. If native fistula placement was not possible or failed, a prosthetic conduit would be the best substitute. The purpose of this prospective study was to compare outcomes of two different sizes of polytetrafluoroethylene (PTFE) grafts, in hemodialysis patients, at the Mustafa Khomeini Hospital in Iran. The study population consisted of 586 end-stage renal disease referrals for vascular access construction (January 2003 to January 2007) of which eventually 102 subjects were candidates for PTFE graft who were followed for one year. Data were collected by a questionnaire and analyzed using the SPSS, life table, Kaplan- Meier and Log-Rank tests. Out of 102 PTFE implantation candidates (mean value of age 51.7 +/- 17.06 yrs), 56% were male and 44% female. PTFE grafts of 8 mm and 6 mm sizes were randomly placed in 57 and 45 subjects, with distribution of 83%, 12% and 5% in arm, forearm and thigh. The most underlying diseases were hypertension and diabetes. There was a significant difference in complication rates between patients with and without underlying diseases [42% vs. 10% (P = 0.03)]. One-year patency rates were 42.2% and 36.5% for 6 mm and 8 mm grafts and 28.2% vs. 52% in patients with and without underlying diseases respectively. Despite more complication frequency in 8 mm grafts, the patency and complication rates of two graft groups did not significantly differ. Hypertension and diabetes could have contributory roles in graft complication rate, which may be preventable. Non-tapered grafts of 6 mm and 8 mm sizes have not significant different outcomes. Further research is recommended with larger sample size and longer duration.
Keywords: Hemodialysis; polytetrafluoroethylene graft; vascular access.
Conflict of interest statement
Figures
Similar articles
-
Early Cannulation of Bovine Carotid Artery Graft Reduces Tunneled Dialysis Catheter-Related Complications: A Comparison of Bovine Carotid Artery Graft Versus Expanded Polytetrafluoroethylene Grafts in Hemodialysis Access.Vasc Endovascular Surg. 2019 Feb;53(2):104-111. doi: 10.1177/1538574418813595. Epub 2018 Nov 29. Vasc Endovascular Surg. 2019. PMID: 30497352
-
Early Experience With a Novel Hybrid Vascular Graft for Hemodialysis Access Creation in Patients With Disadvantaged Anatomy.J Endovasc Ther. 2015 Oct;22(5):778-85. doi: 10.1177/1526602815598754. Epub 2015 Jul 31. J Endovasc Ther. 2015. PMID: 26232398
-
PTFE grafts versus tunneled cuffed catheters for hemodialysis: which is the second choice when arteriovenous fistula is not feasible?Artif Organs. 2015 Feb;39(2):134-41. doi: 10.1111/aor.12353. Epub 2014 Sep 10. Artif Organs. 2015. PMID: 25205079
-
A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. J Vasc Surg. 2014. PMID: 24973288 Review.
-
Use of short PTFE segments (<6 cm) compares favorably with pure autologous repair in failing or thrombosed native arteriovenous fistulas.J Vasc Surg. 2005 Jan;41(1):76-81. doi: 10.1016/j.jvs.2004.10.034. J Vasc Surg. 2005. PMID: 15696048 Review.
Cited by
-
Comparison of Upper Limb Translocated Femoral Vein and Prosthetic Arteriovenous Bridge Grafts.Cureus. 2019 Nov 22;11(11):e6219. doi: 10.7759/cureus.6219. Cureus. 2019. PMID: 31890420 Free PMC article.
-
Implantable Biosensors for Vascular Diseases: Directions for the Next Generation of Active Diagnostic and Therapeutic Medical Device Technologies.Biosensors (Basel). 2025 Feb 25;15(3):147. doi: 10.3390/bios15030147. Biosensors (Basel). 2025. PMID: 40136944 Free PMC article. Review.
References
-
- Hurlbert SN, Mattos MA, Henretta JP, Ramsey DE, Barkmeier LD, Hodgson KJ, et al. Long-term patency rates, complications and cost-effectiveness of polytetrafluoroethylene (PTFE) grafts for hemodialysis access: A prospective study that compares Impra versus Gore-Tex grafts. Cardiovasc Surg. 1998;6:652–6. - PubMed
-
- García-Pajares R, Polo JR, Flores A, Gonzalez-Tabares E, Solís JV. Upper arm polytetrafluoroethylene grafts for dialysis access. Analysis of two different graft sizes: 6 mm and 6-8 mm. Vasc Endovascular Surg. 2003;37:335–43. - PubMed
-
- National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for hemodialysis adequacy, peritoneal dialysis adequacy and vascular access: 2006 Updates. Am J Kidney Dis. 2006;48:S1–S322. - PubMed
-
- Afshar R, Salimi J, Sanavi S, Niazi F, Modaghegh M, Fallah N. One-year efficacy of expanded polytetrafluoroethylene vascular graft in eighty-three hemodialysis patient. Urol J. 2004;1:188–90. - PubMed
-
- Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Kidney Int. 2002;61:2266–71. - PubMed